A61K 39 - Medicinal preparations containing antigens or antibodies

Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/2007
11/06/2007	US7291709 LSR (Lipolysis Stimulated Receptor); for the prevention and/or treatment of pathologies and/or of pathogeneses such as obesity and anorexia, hyperlipidemias, atherosclerosis, diabetes, hypertension
11/06/2007	US7291673 Polymeric biomaterials formed by nucleophilic addition reactions to conjugated unsaturated groups
11/06/2007	US7291613 Inhibitors of p38 kinase
11/06/2007	US7291605 Methods of treating various cancers using melanoma differentiation associated protein-7
11/06/2007	US7291588 Immunogenic detoxified mutant E. coli LT-A toxin
11/06/2007	US7291492 Histone deactylase for use in identifying modulators for prevention and treatment of cell proliferative disorders
11/06/2007	US7291483 FGF-CX polynucleotide sequences and methods of producing same
11/06/2007	US7291462 TADG-15: an extracellular serine protease overexpressed in carcinomas
11/06/2007	US7291453 Isolating DNA or corresponding mRNA from a mutated Hepatitis B Virus and screening for mutations in the HBV DNA polymerase
11/06/2007	US7291452 Erythrovirus and its applications
11/06/2007	US7291344 Administering a botulinum toxin
11/06/2007	US7291343 Therapy for antibiotic resistance; immunotherapy
11/06/2007	US7291342 Immunizing an avian with nonpathogenic immunogenically strain of Georgia 98 (GA-98) virus in attenuated or inactivated form; poultry vaccines
11/06/2007	US7291339 Chimeric polypeptide comprising bifunctional activities for use in medical diagnostics and monitoring protein interaction
11/06/2007	US7291338 Method and device for detecting feline immunodeficiency virus
11/06/2007	US7291337 Stable envelope protein; human t-cell leukemia, lymphoma viruses
11/06/2007	US7291336 Compositions and methods for enhancing immune responses mediated by antigen-presenting cells
11/06/2007	US7291335 Isolated nucleic acid molecules encoding ESO-1 peptides and uses thereof
11/06/2007	US7291334 antibodies that bind to immunogens for diagnosis of enterotoxigenic E. coli infections such as traveler's diarrhea; kits
11/06/2007	US7291333 Blockade of protein C activation reduces microvascular surgical blood loss
11/06/2007	US7291332 Inflammatory mediator antagonists
11/06/2007	US7291331 Administering an amount of an antibody that specifically binds to OX40 ligand (OX4L) sufficient to reduce or inhibit a recall immune response in the pulmonary tissue, or respiratory tract of the mammalian subject.
11/06/2007	US7291330 MD-1 inhibitors as immune suppressants
11/06/2007	US7291329 Antibodies against PRO4406
11/06/2007	CA2363713C Lantibiotic
11/06/2007	CA2271388C Liposomes encapsulating polynucleotides operatively coding for immunogenic polypeptides
11/06/2007	CA2170236C Inducing antibody response against self-proteins with the aid of foreign t-cell epitopes
11/06/2007	CA2079881C Nucleotidic sequences coding for variable regions of .beta. chains of human t lymphocite receptors, corresponding peptidic segments and diagnostic and therapeutic applications
11/06/2007	CA2079879C Nucleotidic sequences coding for alpha chain variable regions in human lymphocite receptors and applications thereof
11/05/2007	CA2651178A1 Immunoglobulin associated cell-surface determinants in the treatment of b-cell disorders
11/01/2007	WO2007124479A2 Avian influenza viruses, vaccines, compositions, formulations, and methods
11/01/2007	WO2007124463A1 Glp-1 compound/glucagon antibody compositions
11/01/2007	WO2007124414A2 Cxcl13 antagonists and their use for the treatment of inflammatory diseases
11/01/2007	WO2007124082A2 Buffering agents for biopharmaceutical formulations
11/01/2007	WO2007123906A2 Recombinant antigens for diagnosis and prevention of murine typhus
11/01/2007	WO2007123765A2 Neutrokine-alpha and neutrokine-alpha splice variant
11/01/2007	WO2007123680A2 Methods and compositions for treating neurodegenerative disorders and alzheimer's disease and improving normal memory
11/01/2007	WO2007123667A2 Membrane-permeant peptide complexes for treatment of sepsis
11/01/2007	WO2007123661A2 Treatment of tumors expressing mutant egf receptors
11/01/2007	WO2007123591A1 Ctsp cancer-testis antigens
11/01/2007	WO2007123562A2 Anthrax therapies, compositions, and methods related thereto
11/01/2007	WO2007123400A1 Vaccine against nicotine addiction
11/01/2007	WO2007123233A1 Gene associated with arteriosclerotic disease, and use thereof
11/01/2007	WO2007123010A1 Agent for improving bone metabolism
11/01/2007	WO2007122820A1 Diagnostic agent and therapeutic agent for pancreatic cancer
11/01/2007	WO2007122815A1 Bivalent antibody directed against bir1
11/01/2007	WO2007122756A1 Therapeutic agent for allergy containing liposome having oligosaccharide on its surface
11/01/2007	WO2007122402A1 Use of antagonists of cxcl13 or cxcr5 for treating wounds or fibrotic diseases
11/01/2007	WO2007122392A1 Composition comprising a cytotoxic t-cell - inducing adjuvant
11/01/2007	WO2007122371A1 ANTI-FACTOR XIIa THERAPY
11/01/2007	WO2007121893A1 Method for treating hpv infected patients
11/01/2007	WO2007121491A1 Hcv vaccinations
11/01/2007	WO2007098717A3 Chimeric vaccine antigens against classical swine fever virus
11/01/2007	WO2007097980A9 Ubiquitin/proteasome inhibitors for the treatment of spinal muscular atrophy
11/01/2007	WO2007095976A3 Adjuvant in the form of a lipid-modified nucleic acid
11/01/2007	WO2007094854A9 Rna virus vaccines and methods
11/01/2007	WO2007089470A9 Antigen-binding proteins targeting s. aureus orf0657n
11/01/2007	WO2007082001A3 Extract of r. miehei
11/01/2007	WO2007064972A3 Monoclonal antibodies against amyloid beta protein and uses thereof
11/01/2007	WO2007053661A3 Uses of anti-cd40 antibodies
11/01/2007	WO2007044620A3 Optimal polyvalent vaccine for cancer
11/01/2007	WO2007025178A3 Rolyvalent multimeric compositions containing active polypeptides, pharmaceutical compositions and methods of using the same
11/01/2007	WO2007008712A8 Anti-alpha v beta 6 antibodies and uses thereof
11/01/2007	WO2007005955A3 Anti-il-23 antibodies, compositions, methods and uses
11/01/2007	WO2007002470A3 Inactivated chimeric vaccines and related methods of use
11/01/2007	WO2007002139A3 Neuroprotection of retinal ganglion cells
11/01/2007	WO2006135738A3 Devices from prion-like proteins
11/01/2007	WO2006133013A3 Methods of generating protein variants with altered function
11/01/2007	WO2006102272A8 Methods for treating tumors and cancerous tissues
11/01/2007	WO2006083183A9 Use of myostatin (gdf-8) antagonists for treatment of sarcopenia (age-related muscle-wasting)
11/01/2007	WO2006083182A9 Use of myostatin (gdf-8) antagonists for improving wound healing and preventing fibrotic disease
11/01/2007	WO2005121330A3 Isolated chimeric proteins of modified lumazine synthase
11/01/2007	WO2005052115A3 Use of parasitic biological agents for diseases prevention and control
11/01/2007	WO2004032622A8 Production of peptides in plants as viral coat protein fusions
11/01/2007	WO2002079435A3 Transgenic mice containing gpcr-like gene disruptions
11/01/2007	US20070255043 MN gene and protein
11/01/2007	US20070254851 Chemically-defined non-polymeric valency platform molecules and conjugates thereof
11/01/2007	US20070254844 biodrug contains an immunogenic peptide; encoded from an isolated host cell transfected with the recombinant expression vector; diagnosis of skin cancer; vaccine for prevention and treatment; immunotherapy
11/01/2007	US20070254316 Peptides for targeting the prostate specific membrane antigen
11/01/2007	US20070254287 Diagnostics and Therapeutics for Diseases Associated with Dipeptidyl-Peptidase 10 (Dpp10)
11/01/2007	US20070253986 Method For Producing Multiple Emulsions That Are Stable In Storage
11/01/2007	US20070253985 Novel processes for coating container means which inhibit precipitation of polysaccharide-protein conjugate formulations
11/01/2007	US20070253984 Novel formulations which stabilize and inhibit precipitation of immunogenic compositions
11/01/2007	US20070253983 Augmentation of titer for vaccination in animals
11/01/2007	US20070253982 Compositions that include hemagglutinin, methods of making and methods of use thereof
11/01/2007	US20070253981 Canine influenza virus
11/01/2007	US20070253980 New pharmaceutical composition from natural materials for regulating immunity, its preparation method and use
11/01/2007	US20070253979 Whole killed HIV virus devoid of outer envelope protein; incomplete Freund's Adjuvant; enhance beta chemokine levels, interferon gamma, cytotoxic T lymphocyte response; slows progression to AIDS; reduces viral burden; infant, child, pregnant; administer subcutaneously, intramuscularly, intramucosally
11/01/2007	US20070253978 Copy choice recombination and uses thereof
11/01/2007	US20070253977 Recombinant respiratory syncytial virus (RSV) strains deleted of the region of G protein most likely to induce unwanted type 2 T cell responses in susceptible recipients; engineered using reverse genetics with deletions of amino acids 151-221 and 178-219; for immunogenic compositions against RSV
11/01/2007	US20070253976 Compositions and methods comprising KLK3 of FOLH1 antigen
11/01/2007	US20070253975 Methods for preventing strokes by inducing tolerance to E-selectin
11/01/2007	US20070253974 Elicits the production of antibodies that interfere with invasion by Babesia bovis into erythrocytes, diagnosis
11/01/2007	US20070253973 Fusion proteins comprising alpha fetoprotein
11/01/2007	US20070253972 For expressing foreign genetic information, e.g. foreign genes, for many applications, including immunogenic or pharmaceutical compositions for pathogens other than mumps, gene therapy, and cell targeting
11/01/2007	US20070253971 Circovirus sequences associated with piglet weight loss disease (PWD)
11/01/2007	US20070253970 Enzymatic polypeptide sequences which target and destroy cancer cells
11/01/2007	US20070253969 Materials and methods relating to DNA vaccination
11/01/2007	US20070253968 Identification of peptides that facilitate uptake and cytoplasmic and/or nuclear transport of proteins, DNA and viruses
11/01/2007	US20070253967 Agent for the treatment and/or prophylaxis of microcirculatory disorders

1 ... 810 811 812 813 814 815 816 817 818 819 820 821 822 823 824 825 826 827 828 829 830 ... 1823